FSDDF News and Press, FSD Pharma Inc - Class B From 09/25/19

- Joint Venture to develop, manage and operate cannabis extraction and processing center at FSD Pharma Facility in Cobourg, Ontario - FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) (“FSD Pharma”, “FSD” or “the Company”) today announced t...

Phoenix, Arizona--(Newsfile Corp. - September 12, 2019) - The Stock Day Podcast welcomed FSD Pharma (OTCQB: FSDDF) ("the Company"), a company focused on the research and development of novel cannabinoid-based treatments for several central nervous system disorders including chronic pain, fibro...

FSD Pharma ( OTCQB:FSDDF ) has launched  a private placement of up to $5M of its class B subordinate voting shares at C$0.10/Share without any warrant coverage. More news on: FSD Pharma Inc., Healthcare stocks news, Read more ...

Also Reports Q2 2019 Financial Results FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company") is pleased to announce that the Company has launched a private placement of up to US$5 million of its class B subordinate voting shares (“Shares”) at a pr...

During the past trading week (August 19 to 23), a multi-state operator (MSO) offered an update on federal reviews for an acquisition it plans to make. The second lottery in Ontario to determine what companies and individuals may get to open new cannabis stores in the province made headlines,...

FSD Pharma Launches Online Ordering System for Medicinal Cannabis Fulfillment Canada NewsWire TORONTO, Aug. 21, 2019 Orders for medicinal cannabis can be placed on fvpharma.com TORONTO , Aug. 21, 2019 /CNW/ - FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ...

Expands the Scientific Advisory Board by adding three additional prominent researchers in clinical applications of medicinal cannabis Adam Friedman, MD, FAAD, Ken Mackie, MD and Sara Jane Ward, Ph.D. join high-profile FSD Scientific Advisory Team FSD Pharma Inc. (CSE: HUGE) (OTC...

FSD Pharma ( OTCQB:FSDDF ) has finalized the acquisition of Prismic Pharmaceuticals' all of the issued and outstanding common and preferred shares valued at $17.5M. More news on: FSD Pharma Inc., Healthcare stocks news, Read more ...

FSD Pharma ( OTCQB:FSDDF ) has finalized the acquisition of Prismic Pharmaceuticals' all of the issued and outstanding common and preferred shares valued at $17.5M. More news on: FSD Pharma Inc., Healthcare stocks news, Read more ...

FSD acquires platform company to advance R&D of targeted application of micro-Palmitoylethanolamide impacting the human endocannabinoid system FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) and Prismic Pharmaceutica...